Anti‐synthetase syndrome associated interstitial lung disease after combination dual immune checkpoint inhibition

Immune checkpoint inhibitors (ICIs) unleash potent anti‐tumour responses but with frequent off‐target immune‐mediated adverse events (irAE). ICIs can induce a spectrum of rheumatologic manifestations including inflammatory arthritis, Sjögren's syndrome, scleroderma and systemic lupus erythemato...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Peter T., Beaton, Thomas, Terrill, Matthew, Gillis, David, Goddard, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009905/
https://www.ncbi.nlm.nih.gov/pubmed/36923607
http://dx.doi.org/10.1002/rcr2.1115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009905/
https://www.ncbi.nlm.nih.gov/pubmed/36923607
http://dx.doi.org/10.1002/rcr2.1115

Ejemplares similares